Share Price:

APNASPENAspen Pharmacare Hldgs1759170 (0.40%)

Media Coverage

Television | May 2023

7 May 2023

Stephen Saad | Eleni Giokos– CNN Connecting Africa

African Continental Free Trade Area Business Forum

Television

18 April 2023

Stavros Nicolaou | Devan Murguran – eNCA South Africa

17 April 2023

Stavros Nicolaou | Katlego Legodi – SABC News

18 April 2023

Stavros Nicolaou | Ntokozo Khumalo – Newzroom Afrika

Radio / Podcasts

13 April 2023

Stavros Nicolaou | Fifi Peters – SaFM: Market Update for Moneyweb

13 April 2023

Stavros Nicolaou | Lulu Gaboo – SABC Channel Africa: Africa in Business

South Africa Investment Conference

Television

13 April 2023

Stavros Nicolaou | Liabo Setho, Economics Reporter – SABC News

13 April 2023

Stavros Nicolaou | Gareth Edwards – eNCA

13 April 2023

Stavros Nicolaou | Zanele Morrisson – CNBC Africa

Radio / Podcasts

13 April 2023

Stavros Nicolaou | Sakinna Kamwendo – SaFM: Update at Noon

Television | March 2023

17 March 2023
South Africa – Tanzania Business Forum Outcomes

Aspen 2023 Interim Results

Television

1 March 2023
Stephen Saad | Zinathi Gquma – Business Day TV: News Leader
1 March 2023
Stephen Saad | Tania Habimana CNBC Africa
1 March 2023
Stephen Saad | Sally Burdett – eNCA : South Africa Tonight
1 March 2023
Stephen Saad | Xolani Mbanjwa – Newzroom Afrika: NewsFeed

Digital

1 March 2023
Stephen Saad | Bronwyn Nielsen – The Nielsen Network: C-Suite

Radio / Podcasts

1 March 2023
Stephen Saad | Bruce Whitfield The Money Show
1 March 2023
Sean Capazorio | Fifi Peters SAFM: Market Update
1 March 2023
Sean Capazorio| Jimmy Moyaha Power 98.7: Power Business

Television | February 2023

18 February 2023
eNCA’s Tumelo Mothotoane and Stavros Nicolaou discuss Aspen’s donations of critical medicines to victims of the earthquakes in Turkey and Syria
23 February 2023
Godfrey Mutizwa hosts Stephen Saad, Aspen Group Chief Executive, on CNBC Africa’s Captains of Industry

Media Enquiries

Shauneen Beukes
Group Communications Consultant
+27 31 580 8600
+27 82 389 8900
sbeukes@aspenpharma.com

Share on social

Follow on social

Closed Period

Aspen is in a closed period from 1 January until the publication of our interim results on the JSE SENS platform scheduled to be released on 1 March 2023.

The live presentation will take place in Cape Town at 08h30 on 2 March 2023.